← Back to headlines
FDA Clears Roche and Eli Lilly's Alzheimer's Blood Test
The U.S. Food and Drug Administration (FDA) has granted clearance for an Alzheimer's blood test developed by pharmaceutical companies Roche and Eli Lilly. This approval marks a significant advancement in the diagnosis of the neurodegenerative disease.
24 Aug, 11:55 — 24 Aug, 14:02
The Story
Analyzing sources…
Source Diversity
Source Diversity
High (63/100)5 sources33/33
Spectrum spread— 3/5 buckets covered17/33
Far L
Left1
Left (1)
Yahoo
Center2
Center (2)
forbesReuters
Right2
Right (2)
straits-timeswsj
Far R
Geographic diversity— 3 regions13/34
US3Singapore1Intl1
Sources
Showing 5 of 5 sources
ReutersVery High7h ago
Roche, Eli Lilly's Alzheimer's blood test gets FDA clearance - Reuters
Roche, Eli Lilly's Alzheimer's blood test gets FDA clearance Reuters
Read full article →wsjHigh8h ago
FDA Approves Alzheimer’s Blood Test Developed by Roche and Eli Lilly - WSJ
FDA Approves Alzheimer’s Blood Test Developed by Roche and Eli Lilly WSJ
Read full article →forbes7h ago
FDA Clears Roche And Eli Lilly’s Alzheimer’s Blood Test
The new test promises to be “minimally invasive” and can help doctors identify symptoms of Alzheimer’s disease earlier.
By Zachary Folk, Forbes Staff
Read full article →YahooMostly Factual9h ago
Roche, Eli Lilly's Alzheimer's blood test gets FDA clearance
Read full article →straits-timesMostly Factual7h ago
Roche, Eli Lilly’s Alzheimer’s blood test gets US FDA clearance - The Straits Times
Roche, Eli Lilly’s Alzheimer’s blood test gets US FDA clearance The Straits Times
Read full article →Coverage Timeline
First report: Yahoo · 24 Aug, 11:55|Full coverage: 5 · 2h|Window: 2h
Left-leaningCenterRight-leaning
